Aytu biopharma announces publication of in vitro study demonstrating that ultraviolet-a light increases mitochondrial anti-viral signaling protein within cells

Englewood, co / accesswire / may 12, 2021 / aytu biopharma, inc. (nasdaq:aytu), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced today that in vitro data related to the ultraviolet (uv) a light used in the healight™ uva endotracheal catheter technology was published in biorxiv, an online archive for health science manuscripts that are not yet peer reviewed. the manuscript titled "ultraviolet-a light increases mitochondrial anti-viral signaling protein via cell-cell communication" concluded that uva light increases the expression of mitochondrial antiviral-signaling (mavs) protein within cells, and the results suggest that this transmission of an increase in intracellular mavs involves cell-to-cell communication.
AYTU Ratings Summary
AYTU Quant Ranking